Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04776655 |
| Title | Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB (LIBImAb) |
| Acronym | LIBImAb |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | Azienda Unita Sanitaria Locale Reggio Emilia |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA |
CKB BOOST